Micro-technology
Innovative, super-elastic and shape-memory materials
Revolutionary performance
Advanced minimally invasiveness to achieve bio-enhanced functionality
Biological integration
Seamless incorporation of technology with human body

Preventing your blindness through innovation

It's not about ideas.
It's about making ideas happen.

Innovative Eye Care Solutions

Recornea technologies prevent blindness through proprietary technology that creates innovative minimally-invasive products for ophthalmic applications. The technology couples minimally invasive surgery with biocompatible and bio-enhanced devices to treat diseases of the eye.

Our technology:

  • Nitinol A super elastic, shape-memory alloy.
  • Biocompatible devices designed for natural integration/engineered for safety.
  • Minimally invasive procedures Faster healing, less pain.

Pioneering the Future of Ophthalmology

RECORNEA pioneers advanced medical solutions for diseases of the eye. Our flagship GROSSO® Reshaper is the world's first-ever nitinol intracorneal implant designed to treat keratoconus, a condition that causes progressive thinning and bulging of the cornea resulting in poor quality of vision. By leveraging the unique properties of shape-memory and super-elastic materials, we are developing a pipeline of innovative minimally-invasive devices to address a wide range of ocular conditions, including glaucoma and keratoconus.

Supported by Fundings & Patents

Recornea raised around €2.4 M in non-dilutive and €0.9 M in dilutive funding for the core platform proprietary technology. Recornea will spin out multiple innovative products such as for glaucoma related ailments and others in the coming years.

Keratoconus - GROSSO® Reshaper

A revolutionary solution for treating keratoconus. An innovative intracorneal implant designed to restore vision and enhance quality of life.

Keratoconus - GROSSO® Reshaper
Read more
Glaucoma

The future of glaucoma treatment with a new filtering device.

Glaucoma
Read more

Updates from Recornea world

Latest News
Public Organizations
Subscribe to our newsletter for the latest news Subscribe newsletter